Uncovering TME’s detailed roles in tumor progression has led to a shift in anti-tumor therapies to include TME’s supportive molecules, such as protein kinases, endothelial growth factors, and superficial receptors [8]. The gene discussed is WEE1; the disease is neoplasm.